vaccines lecture 1 Flashcards

1
Q

what are the 2 major parts of immune system

A
  • innate
  • adaptive
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is the innate immune system

A

First line of defense
- Responds quickly to invaders
- Primed and ready to fight at all times
- No adaptation in response (same response on re-exposure)
- Acts to confine invader and stops spread
- No memory persists afterwards

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what is the adaptive immune system

A

Second line of defense
- Slower response
- Adapts to invaders (faster and stronger response on re-exposure)
- Memory persists afterwards

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

The innate immune system has 3 main part what are they

A
  • physical barriers
  • chemical barriers
  • cellular barriers
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

The adaptive immune system has 2 main part what are they

A
  • B cells
  • T cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what are the types of immunity

A
  • Passive
  • active
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what is passive immunity

A
  • can be natural or artificial
  • natural: Antibodies transmitted from mother to baby
  • artificial: Antibodies acquired from a medicine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what is active immunity

A
  • can be natural or artificial
  • natural: Antibodies developed in response to an infection
  • artificial: Antibodies developed in response to a vaccination
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what is an antigen

A

Antigen = molecular structure which may be present on the outside surface of a pathogen that triggers response an immune.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is an antibody

A

Antibody = proteins produced by B cells. They are specialised Y-shaped proteins that tag antigens for destruction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what is a vaccine

A

Vaccination = when a vaccine has been administered to you

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what is immunisation

A

Immunisation = process of what happens in your body after you have received a vaccine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Give an example of a pathogen

A

SARS-CoV-2 ( Covid-19 )

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe the structure of the SARS-CoV-2 ( Covid-19 ) pathogen

A

SPIKE PROTEINS
- The spike proteins are anchored into the viral envelope and form a crown like appearance. The spike proteins attach to the target cell and allow the virus to enter it

ENVELOPE
- The RNA is surrounded by an envelope which has different roles in the life cycle of the virus. These may include the assembly of the new virus and helping the new virus to leave the infected cell

RNA
- The RNA is inside the envelope and acts as a template so that once it is inside the host cell, the coronavirus can replicate itself and be released into the body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what is the R₀ value

A
  • Term that describes how contagious/transmissible
    an infection disease is
  • R0=Basic Reproduction Number
  • Average number of secondary cases arising from a
    primary infection case in an entirely susceptible population
  • R₀ < 1
  • R₀ = 1
    -R₀ >1
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what is herd immunity

A

Refers to indirect protection of a community of people from a disease by immunising a critical proportion of that population

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is a vaccine?

A
  • A vaccine is a biological preparation
  • Typically contains weakened or inactive parts of a particular disease-causing pathogen
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

what do vaccines do

A
  • Improves immunity to a particular disease
  • Triggers an immune response within the body
  • Relies on the generation of immunological memory
  • Mimics a natural infection without causing illness to the individual
  • Protects not only the vaccinated individual but also their community
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

how do vaccines work

A

Vaccination ‘programs’ the immune system to remember a particular disease pathogen by allowing it to ‘practice’ on a weakened or killed version of the pathogen. This is called primary response to a pathogen

If the pathogen invades the body again in full strength, the immune system is ready to respond quickly. This is called a secondary response to a pathogen. Secondary responses happen faster and at a greater magnitude than primary responses, resulting in the creation of more antibodies to fight the pathogen and more memory cells to fight it in the future

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

what do an ideal vaccine do

A
  • Produce the same immune protection which usually follows natural infection but without causing disease
  • Generate long lasting immunity
  • Interrupt the spread of infection
21
Q

what are the 3 main types of vaccines

A
  • Whole pathogen vaccines
  • Subunit vaccines
  • Nucleic acid vaccines
  • Viral vectored vaccines
22
Q

Whole pathogen vaccines

A

Live attenuated
Inactivated

23
Q

Subunit vaccines

A

Conjugate
Toxoid
Recombinant protein

24
Q

Nucleic acid vaccines

A

RNA

25
Q

Viral vectored vaccines

A

Viral vectored

26
Q

Live attenuated vaccines

A

Obtained from live pathogenic organisms

Pathogenic organisms are treated to become attenuated (or weakened) – lose capacity to induce full-blown disease but retain immunogenicity

Pathogenic organism is attenuated by introducing it into a species in which it does not replicate well or forcing it to replicate repeatedly in tissue culture

Activates T-killer cells

27
Q

advantages of Live attenuated vaccines

A

Most potent of all types of vaccines – mimic real infection
Produces a strong immune response
Typically produce long-term immunity after one or two doses

28
Q

Limitations of Live attenuated vaccines

A

Potential to revert to virulent/infectious form
Poor stability – require strict control of storage and transport conditions
Should not be administered to immunocompromised patients (e.g. blood cancer patients, pregnant women, chemo/radiation therapy patients)

29
Q

Examples of Live attenuated vaccines

A

Part of the routine immunisation schedule
Measles, Mumps and Rubella (MMR)
Rotavirus
Nasal Influenza
Shingles

Travel Vaccines
MMR
Bacillus Calmette-Guerin (BCG) – protection against tuberculosis
Oral Typhoid
Yellow Fever

30
Q

Inactivated vaccines

A

Obtained through thermal of chemical inactivation of pathogenic agents
Pathogens remain immunogenic but can’t replicate within the host

31
Q

advantages of Inactivated vaccines

A

Safer than live attenuated vaccines (low risk of reverting to the virulent, infected form)
Usually more stable than live attenuated vaccines – easier to store and transport

32
Q

Limitations of Inactivated vaccines

A

Excessive inactivation treatment can destroy immunogenicity
Insufficient treatment can leave infectious agents present in the vaccine
Requires mandatory booster immunisations

33
Q

Examples of inactivated vaccines

A

Part of the routine immunisation schedule
Polio
Injectable Influenza
Hepatitis A (specialist groups only)

Travel Vaccines
Cholera
Hepatitis A
Japanese Encephalitis
Polio
Rabies
Tick-borne Encephalitis
Injectable Typhoid

34
Q

Subunit vaccines

A

One or more antigenic fragments of the pathogen (e.g. proteins, polysaccharides, capsid) are used to stimulate the immune response

Antigens may be obtained through recombinant protein expression, production in yeast cells or bacteria or extraction from infected cells

Generally require addition of an adjuvant

35
Q

advantages of Subunit vaccines

A

Immune response can focus on antigenic fragment of the pathogen only
Safer than whole pathogen vaccines because do not contain whole pathogen
Usually more stable than whole pathogen vaccines – easier to transport and distribute
Can be given safely to immunocompromised patient

36
Q

Limitations of Subunit vaccines

A

Highly complicated manufacturing process, requiring synthesis, isolation and purification steps to obtain the antigen
Less immunogenic than whole pathogen vaccines – requires booster immunisations
Local side effects (e.g. sore at injection site) more common with these types of vaccines

37
Q

Conjugate vaccines

A

Made using the polysaccharides, or sugars, that form the outer coating of many bacteria

Part of the routine immunisation schedule
Haemophilus influenza type b (Hib)
Pneumococcal
Meningococcal ACWY

Travel Vaccines
Meningococcal ACWY

38
Q

Toxoid vaccines

A

Made using inactivated version of bacteria releasing toxins
Elicit immune responses against disease-causing proteins, or toxins, secreted by the bacteria
Called ‘toxoids’ because they look like toxins but are not poisonous
Part of the routine immunisation schedule
Diphtheria
Tetanus
Pertussis

Travel Vaccines
Tetanus

39
Q

Recombinant Protein vaccines

A

madeusingbacterial or yeast cells to manufacture the vaccine

Part of the routine immunisation schedule
Human papillomavirus (HPV)
Hepatitis B (specialist groups only)
Meningococcal (MenB)

Travel Vaccines
Hepatitis B

40
Q

Nucleic acid vaccines

A

Unlike other vaccines, these vaccines do not supply the protein antigen to the body
Provide the genetic material (DNA or RNA) of specific antigens to develop immunity
Nucleic Acid Vaccines include: DNA and RNA Vaccines

41
Q

advantages of Nucleic acid vaccines

A

Safer than whole pathogen vaccines because do not contain whole pathogen
Relatively easy to manufacture

42
Q

Limitations of Nucleic acid vaccines

A

RNA vaccines requires ultra low storage
(< - 70°C)
Booster immunisations may be necessary

43
Q

examples of Nucleic acid vaccines

A

RNA vaccines use messenger RNA (mRNA) inside a lipid (fat) membrane
RNA vaccines are not capable of combining with the human genetic code (DNA)
COVID-19
- BioNTech Pfizer
- Moderna

44
Q

RNA vaccines

A

Messenger ribonucleic acid (mRNA) vaccine
Contains the genetic sequence (mRNA) for the spike protein, which is found on the surface of the SARS-CoV-2 virus, wrapped in a lipid envelope
When injected, the mRNA is taken up by the host’s cells, which translate the genetic information and produce the spike proteins
This stimulates the immune system to produce antibodies and activate T-cells

45
Q

Viral vectored vaccines

A

Like nucleic acid vaccines, these vaccines do not supply the protein antigen to the body
Provide the genetic material (DNA or RNA) of the antigen to host cells using a safe virus
In turn, the cells produce the antigen which stimulates an immune response
Viral vectored vaccines include: Replicating and non-replicating vaccines

46
Q

advantages of Viral vectored vaccines

A

Safer than whole pathogen vaccines because do not contain whole pathogen
Relatively easy to manufacture
Cheaper to produce than nucleic acid vaccines and subunit vaccines

47
Q

Limitations of Viral vectored vaccines

A

Booster immunisations may be necessary

48
Q

examples of Viral vectored vaccines

A

Non-replicating viral vectors do not retain the ability to make new viral particles during the process of delivering the vaccine antigen to the cell
COVID-19
- Oxford AstraZeneca

49
Q

Viral vectored vaccines

A

Non-replicating viral vector vaccine
Uses part of a weakened adenovirus as a carrier to deliver the genetic sequence for the SARS-CoV-2 virus spike protein into cells
When injected, the modified adenovirus binds to the surface of human cells and delivers the genetic code (mRNA) for the spike protein
This stimulates the immune system to produce antibodies and activate T-cells